Cytek Biosciences Inc
NASDAQ:CTKB
Cytek Biosciences Inc
NASDAQ:CTKB
Price:
6.1 USD
-1.29%
Market Closed
Updated:
May 19, 2024
Operating Margin
Cytek Biosciences Inc
Cytek Biosciences Inc
-13.2%
Current
-4%
Average
2.7%
Industry
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin
=-13.2%
Operating Profit
/
-26.4m
Revenue
200.8m
Operating Margin Across Competitors
| Country | US |
| Market Cap | 800.7m USD |
| Operating Margin |
-13%
|
| Country | US |
| Market Cap | 227.2B USD |
| Operating Margin |
17%
|
| Country | US |
| Market Cap | 196.9B USD |
| Operating Margin |
22%
|
| Country | US |
| Market Cap | 45.2B USD |
| Operating Margin |
19%
|
| Country | US |
| Market Cap | 42B USD |
| Operating Margin |
14%
|
| Country | CH |
| Market Cap | 38.2B CHF |
| Operating Margin |
20%
|
| Country | KR |
| Market Cap | 56.1T KRW |
| Operating Margin |
30%
|
| Country | US |
| Market Cap | 32.5B USD |
| Operating Margin |
29%
|
| Country | IE |
| Market Cap | 26B USD |
| Operating Margin |
13%
|
| Country | US |
| Market Cap | 26B USD |
| Operating Margin |
23%
|
| Country | US |
| Market Cap | 21.1B USD |
| Operating Margin |
27%
|
Profitability Report
View the profitability report to see the full profitability analysis for Cytek Biosciences Inc.
See Also
Discover More
What is Operating Margin?
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin
=-13.2%
Operating Profit
/
-26.4m
Revenue
200.8m
What is the Operating Margin of Cytek Biosciences Inc?
Based on Cytek Biosciences Inc's most recent financial statements, the company has Operating Margin of -13.2%.
You don't have any saved screeners yet
